Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
93.36M | 87.93M | 75.26M | 69.62M | 55.03M | 49.63M | Gross Profit |
25.09M | 22.83M | 19.57M | 18.40M | 14.26M | 13.23M | EBIT |
9.61M | 9.42M | 8.31M | 8.45M | 5.48M | 5.16M | EBITDA |
10.08M | 11.89M | 9.42M | 9.34M | 6.39M | 6.11M | Net Income Common Stockholders |
7.87M | 7.65M | 6.73M | 6.65M | 4.33M | 4.16M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
8.37M | 8.37M | 9.15M | 10.48M | 7.37M | 4.39M | Total Assets |
41.30M | 41.30M | 37.88M | 37.40M | 33.26M | 29.55M | Total Debt |
2.37M | 2.37M | 648.03K | 1.11M | 1.55M | 2.00M | Net Debt |
-5.99M | -5.99M | -8.50M | -9.37M | -5.82M | -2.39M | Total Liabilities |
24.36M | 24.36M | 20.02M | 18.52M | 16.67M | 15.44M | Stockholders Equity |
16.94M | 16.94M | 17.86M | 18.88M | 16.59M | 14.11M |
Cash Flow | Free Cash Flow | ||||
5.29M | 7.46M | 7.17M | 8.27M | 5.45M | 3.63M | Operating Cash Flow |
5.32M | 7.53M | 7.23M | 8.31M | 5.50M | 4.04M | Investing Cash Flow |
1.74M | 1.46M | 157.73K | -32.35K | -11.79K | -251.51K | Financing Cash Flow |
-10.09M | -9.78M | -8.72M | -5.17M | -2.51M | -5.74M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £336.76M | 12.49 | 34.33% | 3.74% | 29.83% | 60.50% | |
73 Outperform | £169.34M | 21.44 | 43.76% | 3.49% | 12.22% | 7.48% | |
73 Outperform | £865.34M | 16.95 | 35.07% | 4.04% | -4.13% | 23.09% | |
63 Neutral | $4.14B | 11.23 | 5.47% | 215.40% | 4.10% | -8.63% | |
62 Neutral | £153.93M | 63.01 | 3.11% | 4.15% | 13.88% | 512.00% | |
56 Neutral | £24.43M | 40.79 | 3.66% | 3.23% | 4.14% | -45.24% | |
41 Neutral | £131.01M | ― | -6.25% | ― | 0.81% | 15.63% |